MIRA Pharmaceuticals, Financials
| MIRA Stock | 1.15 0.07 5.74% |
MIRA |
Please note, the presentation of MIRA Pharmaceuticals,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MIRA Pharmaceuticals,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MIRA Pharmaceuticals,'s management manipulating its earnings.
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 60458C104 |
| Location | Maryland; U.S.A |
| Business Address | 1200 Brickell Avenue, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | mirapharmaceuticals.com |
| Phone | 786 432 9792 |
MIRA Pharmaceuticals, Key Financial Ratios
| Return On Equity | -1.92 | ||||
| Return On Asset | -0.81 | ||||
| Target Price | 17.75 |
MIRA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MIRA Pharmaceuticals,'s current stock value. Our valuation model uses many indicators to compare MIRA Pharmaceuticals, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MIRA Pharmaceuticals, competition to find correlations between indicators driving MIRA Pharmaceuticals,'s intrinsic value. More Info.MIRA Pharmaceuticals, Common is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MIRA Pharmaceuticals,'s earnings, one of the primary drivers of an investment's value.MIRA Pharmaceuticals, Systematic Risk
MIRA Pharmaceuticals,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MIRA Pharmaceuticals, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on MIRA Pharmaceuticals, correlated with the market. If Beta is less than 0 MIRA Pharmaceuticals, generally moves in the opposite direction as compared to the market. If MIRA Pharmaceuticals, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MIRA Pharmaceuticals, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MIRA Pharmaceuticals, is generally in the same direction as the market. If Beta > 1 MIRA Pharmaceuticals, moves generally in the same direction as, but more than the movement of the benchmark.
About MIRA Pharmaceuticals, Financials
What exactly are MIRA Pharmaceuticals, Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include MIRA Pharmaceuticals,'s income statement, its balance sheet, and the statement of cash flows. Potential MIRA Pharmaceuticals, investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although MIRA Pharmaceuticals, investors may use each financial statement separately, they are all related. The changes in MIRA Pharmaceuticals,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MIRA Pharmaceuticals,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.MIRA Pharmaceuticals, Thematic Clasifications
MIRA Pharmaceuticals, Common is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Pharmaceutical Products | View |
MIRA Pharmaceuticals, March 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MIRA Pharmaceuticals, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MIRA Pharmaceuticals, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of MIRA Pharmaceuticals, Common based on widely used predictive technical indicators. In general, we focus on analyzing MIRA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MIRA Pharmaceuticals,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 4.58 | |||
| Information Ratio | 0.0142 | |||
| Maximum Drawdown | 33.47 | |||
| Value At Risk | (7.27) | |||
| Potential Upside | 9.57 |
Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |